NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

臨床化學分析設備的全球市場:成長,趨勢,及預測

Clinical Chemistry Analyzers Market - Growth, Trends, and Forecasts (2020 - 2025)

出版商 Mordor Intelligence Pvt Ltd 商品編碼 911968
出版日期 內容資訊 英文 114 Pages
商品交期: 2-3個工作天內
價格
臨床化學分析設備的全球市場:成長,趨勢,及預測 Clinical Chemistry Analyzers Market - Growth, Trends, and Forecasts (2020 - 2025)
出版日期: 2020年06月01日內容資訊: 英文 114 Pages
簡介

本報告提供全球臨床化學分析設備市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,產品類型·檢驗類型·終端用戶·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 成長要素
  • 阻礙因素
  • 波特的五力分析

第5章 市場區隔

  • 各產品類型
    • 分析器
    • 試劑
    • 其他
  • 各檢驗類型
    • 肝板
    • 電解質板
    • 甲狀腺功能板
    • 脂質譜
    • 其他
  • 各終端用戶
    • 醫院
    • 診斷研究所
    • 學術機構
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Abbott Laboratories
    • Danaher Corporation (Beckman Coulter, Inc.)
    • Elitech Group
    • F.Hoffmann-La Roche Ltd.
    • Horiba, Ltd.
    • Johnson & Johnson
    • Mindray Medical International Limited
    • Siemens Healthcare Private Limited
    • Sysmex Corporation
    • Thermo Fisher Scientific Inc.

第7章 市場機會及今後趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 66791

The major factors for the growth of the clinical chemistry analyzers market include the rising geriatric population and increasing prevalence of chronic diseases, increasing importance and awareness of point-of-care testing, and rising technological advancements in clinical chemistry analyzer.

The clinical chemistry analyzers run assays on clinical samples such as blood, plasma, urine, and cerebrospinal fluid in order to detect the presence of analytes relating to disease or drugs. The major factor driving the growth of the market includes rising geriatric population and increasing prevalence of chronic diseases. According to the United States Census Bureau's Statistics, as of 2017, the total number of people aged 65 years and older exceeded 50 million, and between 2020 and 2030, the number of elderly people is projected to increase by almost 18 million. Although much smaller in total size, the number of people aged 85 years and older is expected to more than triple from an estimated 6 million, in the present scenario, to nearly 20 million by 2060. The rising geriatric population will lead to an increase in various diseases resulting in the high demand for clinical tests. Thus, the clinical chemistry analyzers market is expected to witness high growth over the forecast period.

Key Market Trends

Analyzers in Product Type Segment are Expected to Witness Fastest Growth over the Forecast Period

The analyzers are the instruments which analyze the sample such as blood serum and urine. The clinical chemistry analyzers are witnessing high growth owing to the rising technological advancements in the instruments. The market players are focusing on providing cost-effective equipment to end-user. The automation has become pervasive in clinical laboratories around the world. In order to reduce the healthcare costs, laboratories have relied on automation to maintain profitability as well.

Furthermore, in November 2018, the Primary Health Care has joined forces with Siemens Healthineers to deploy more than 70 Atellica Solution immunoassay and clinical chemistry analyzers. Thus, the rising technological advancements in the analyzers expected to propel the overall growth of the Clinical Chemistry Analyzers market.

North America is Expected to Dominate the Market

According to the Centers for Disease Control and Prevention, chronic diseases were the leading cause of death and disability in the United States. In addition, rising healthcare expenditure, along with the rapid adoption of point-of-care testing, is expected to boost the growth of the market. The major market players are launching new technologically advanced products in the market. For instance, recently in September 2019, one of the major market player Siemens Healthineers announced the global commercial availability of its Atellica Solution automation-ready immunoassay and chemistry analyzers and DynLife ( healthcare facility in Canada) was the first to adopt this solution. Thus, owing to the all above-mentioned factors North America is expected to hold largest share in the Clinical Chemistry Analyzers Market.

Competitive Landscape

The market studied is a fragmented market owing to the presence of various market players. Some of the market players are Abbott Laboratories, Danaher Corporation (Beckman Coulter, Inc.), Elitech Group, F.Hoffmann-La Roche Ltd., Horiba, Ltd., Johnson & Johnson, Mindray Medical International Limited, Siemens Healthcare Private Limited, Sysmex Corporation, and Thermo Fisher Scientific Inc.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Geriatric Population and Increasing Prevalence of Chronic Diseases
    • 4.2.2 Increasing Importance and Awareness of Point-of-care Testing
    • 4.2.3 Rising Technological Advancements in Clinical Chemistry Analyzer
  • 4.3 Market Restraints
    • 4.3.1 Lack of Trained and Qualified Professionals
    • 4.3.2 High Cost
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Analyzers
    • 5.1.2 Reagents
    • 5.1.3 Others
  • 5.2 By Types of Test
    • 5.2.1 Liver Panels
    • 5.2.2 Electrolyte Panels
    • 5.2.3 Thyroid Function Panels
    • 5.2.4 Lipid Profiles
    • 5.2.5 Others
  • 5.3 By End User
    • 5.3.1 Hospital
    • 5.3.2 Diagnostic Laboratories
    • 5.3.3 Academic Institutes
    • 5.3.4 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Danaher Corporation (Beckman Coulter, Inc.)
    • 6.1.3 Elitech Group
    • 6.1.4 F. Hoffmann-La Roche Ltd.
    • 6.1.5 Horiba, Ltd.
    • 6.1.6 Johnson & Johnson
    • 6.1.7 Mindray Medical International Limited
    • 6.1.8 Siemens Healthcare Private Limited
    • 6.1.9 Sysmex Corporation
    • 6.1.10 Thermo Fisher Scientific Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS